Monday, July 28, 2014

Odor Identification May Be Able to Detect Risk for Cognitive Decline, Study Finds

Olfactory senses may be used for more than determining pleasant or undesirable aromas, that may someday be a tool to assist in predicting risk for memory loss in late life.
From 2004 to 2010, Davangere Devanand, M.B.B.S., M.D., director of geriatric psychiatry at the New York State Psychiatric Institute and a professor of psychiatry at Columbia University, led a series of tests in a multiethnic population of 1,037 senior citizens without a diagnosis of cognitive dysfunction to determine whether a relationship exists between the inability to identify smells and a diagnosis of mild cognitive decline. Odor identification was measured by the University of Pennsylvania Smell Identification Test (UPSIT). 

The results, presented recently at the 2014 Alzheimer’s Association International Conference in Copenhagen, showed that 210 participants transitioned to either dementia or Alzheimer’s disease (AD) during follow-up two to four years after initial UPSIT was administered. Transition to dementia and AD was correlated with lower odor-identification scores on the UPSIT, even after adjusting for demographics, cognitive and functional measures, and apolipoprotein E genotype. Each one-point deduction on the UPSIT was associated with an approximately 10 percent increase in AD risk. 

Dolores Malaspina, M.D., a professor of psychiatry at New York University who has studied the link between olfactory senses and psychiatric illness, told Psychiatric News that, "while sensory and other processes can decline with aging, even in persons without dementia, olfactory process entails important connections in the areas that are most sensitive to the [amyloid-beta] accumulation that is associated with Alzheimer’s pathology. These results show that there may be a great potential in using olfactory-processing tests, along with other measures, to provide an early identification of those at risk for Alzheimer's disease."

To watch Davanand give an overview of the study, "Olfactory Identification Deficits Predict the Transition From MCI to AD in a Multiethnic Community Sample," click here. To read about research on how physiological factors might be used to predict risks of neurocognitive decline, see the Psychiatric News articles, "Plasma APOE Levels Linked to Dementia Risk," and "Hearing Loss in Seniors Linked to Cognitive Decline." 

(Image: Courtesy of the Alzheimer's Association)


The content of Psychiatric News does not necessarily reflect the views of APA or the editors. Unless so stated, neither Psychiatric News nor APA guarantees, warrants, or endorses information or advertising in this newspaper. Clinical opinions are not peer reviewed and thus should be independently verified.